Skip to content

The clinical utility of Clostridium difficile gene detection by BD MAX Cdiff System

The clinical utility of Clostridium difficile gene detection by BD MAX Cdiff System - The clinical study of BD MAX Cdiff System

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000010121
Enrollment
470
Registered
2013-03-01
Start date
2013-03-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium difficile infecction

Interventions

None listed

Sponsors

Nippon Becton Dickinson Company, Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A patient who shows CDAD or is diagnosed as CDI

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
The concordance rate between BD MAX Cdiff System and clinical diagnosis for Clostridium difficile infection

Countries

Japan

Contacts

Public ContactTakeshi Tomaru

Nippon Nippon Becton Dickinson Company, Ltd. Medical Affairs

takeshi_tomaru@bd.com03-6234-5490

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026